A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation

Shiji Fang(Wenzhou Medical University), Jianfei Tu(Lishui Central Hospital), Weiqian Chen(First Affiliated Hospital Zhejiang University), Jinyu Zhu(Nanjing University of Chinese Medicine), Xulu Wu(Wenzhou Medical University), Zhongwei Zhao(Central South University), Liyun Zheng(Nanchang University), Linqiang Lai(Lishui University), Fazong Wu(Wenzhou Medical University), Jiansong Ji(Wenzhou Medical University), Qiaoyou Weng(Wenzhou Medical University), Yuanyuan Xu(Lishui University), Minjiang Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Molecular Biosciences
August 31, 2021
10.3389/fmolb.2021.662366
Cited by 14

Related Papers

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
|Cell Communication and Signaling|2020|232
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
|Scientific Reports|2016|143
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
|Journal of Experimental & Clinical Cancer Research|2020|107
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
|Journal of Hepatology|2021|101
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
|Frontiers in Molecular Biosciences|2021|90